Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BYAdvanced Science

Extracellular CIRP Dysregulates Microglial Efferocytosis in Acute Ischemic Stroke via the TLR4/miR‐155/MafB Axis

  • Dmitriy Lapin1,2
  • Dilara Aylar1
  • Archna Sharma1,2
  • Ping Wang1,2,3
  1. 1Center For Immunology and Inflammation The Feinstein Institutes For Medical Research Manhasset New York USA
  2. 2Department of Molecular Medicine Zucker School of Medicine at Hofstra/Northwell Manhasset New York USA
  3. 3Department of Surgery Zucker School of Medicine at Hofstra/Northwell Manhasset New York USA
Open at sourceDOICite

Abstract

Background: Ischemic stroke remains a leading cause of mortality and disability worldwide, but efforts to develop efficacious neuroprotective therapy face ongoing challenges. Efferocytosis, the phagocytic clearance of dying cells, by microglia is crucial for limiting neuroinflammation and promoting stroke resolution. Extracellular cold-inducible RNA-binding protein (eCIRP) is an inflammatory mediator which impairs macrophage bacterial phagocytosis in sepsis and radiation injury, but its role in microglial efferocytosis in ischemic stroke has not yet been studied. Results: Using a transient middle cerebral artery occlusion (tMCAO) model of ischemic stroke, we demonstrate that eCIRP is released into the cerebrospinal fluid and microglial expression of crucial efferocytic receptor MerTK decreases in tMCAO mice. CIRP deficiency significantly improved neurological deficit, MerTK expression and microglial efferocytosis in tMCAO mice. Utilizing tMCAO, hippocampal injections, and primary microglia, we show that eCIRP induces pro-inflammatory micro-RNA 155 (miR-155) via TLR4, which suppresses its target pro-efferocytic transcription factor MAF bZIP (MafB), downregulating MerTK and microglial efferocytosis. Pharmacological blockade of eCIRP-TLR4 interaction using small peptide C23 attenuates miR-155 induction, restores MerTK expression, rescues microglial efferocytosis, and improves outcomes in tMCAO mice. Conclusion: We show that eCIRP causes microglial efferocytic dysfunction in ischemic stroke via TLR4/miR-155/MafB axis. These findings uncover a previously unknown pathway through which eCIRP signaling impairs neuroprotective function in microglia and suggest that targeting eCIRP may promote functional recovery after stroke.

Related

  1. ZFP36L1 Enhances Microglial Ferroptosis in Ischemic Stroke by Reducing FTO‐Mediated N6‐Methyladenosine Demethylation of ACSL1 mRNA
    Ai‐Xia Song, Han‐Xu Jin, Yuan‐Xin Sun +5
    Kaohsiung Journal of Medical SciencesPeer-reviewedCC BYFull text1 citedNeurologyDOAJ
  2. Early infiltration of ischemia-conditioned Tregs attenuates BBB damage via suppressing neutrophil extracellular traps in ischemic stroke
    Huaming Li, Xiaotao Zhang, Jianan Lu +15
    Cell ReportsPeer-reviewedCC BY 4.0NeurologyCrossref
  3. The A-FABP Nexus in the Neurovascular Unit: Bridging Endothelial Barrier Breakdown and Microglial Lipotoxicity in Ischemic Stroke.
    Wen-Yu Ma, Lan Yao, Wei Lan
    Journal of inflammation researchPeer-reviewedCC BY-NCFull textNeurologyEurope PMC
  4. Cholesterol dysregulation and microglial NLRP3 inflammasome activation after ischemic stroke: implications for neuroinflammation and functional recovery
    Jing Wang, Pingxu An, Chunyan Fu +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMC
  5. RNA processing factors are associated with microglial heterogeneity and intercellular communication in ischemic stroke
    Juanfen Gong, Yingchun He, Yong Zhang +2
    Scientific ReportsPeer-reviewedCC BY 4.0Full textNeurologyCrossref

Cite

BibTeXRIS
BibTeX
@article{lapin2026extracellular,
  title = {{Extracellular CIRP Dysregulates Microglial Efferocytosis in Acute Ischemic Stroke via the TLR4/miR‐155/MafB Axis}},
  author = {Dmitriy Lapin and Dilara Aylar and Archna Sharma and Ping Wang},
  journal = {Advanced Science},
  year = {2026},
  month = aug,
  doi = {10.1002/advs.77053},
  url = {https://doi.org/10.1002/advs.77053},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Extracellular CIRP Dysregulates Microglial Efferocytosis in Acute Ischemic Stroke via the TLR4/miR‐155/MafB Axis
AU  - Dmitriy Lapin
AU  - Dilara Aylar
AU  - Archna Sharma
AU  - Ping Wang
PY  - 2026
DA  - 2026/08/15
JO  - Advanced Science
DO  - 10.1002/advs.77053
UR  - https://doi.org/10.1002/advs.77053
AB  - Background: Ischemic stroke remains a leading cause of mortality and disability worldwide, but efforts to develop efficacious neuroprotective therapy face ongoing challenges. Efferocytosis, the phagocytic clearance of dying cells, by microglia is crucial for limiting neuroinflammation and promoting stroke resolution. Extracellular cold-inducible RNA-binding protein (eCIRP) is an inflammatory mediator which impairs macrophage bacterial phagocytosis in sepsis and radiation injury, but its role in microglial efferocytosis in ischemic stroke has not yet been studied. Results: Using a transient middle cerebral artery occlusion (tMCAO) model of ischemic stroke, we demonstrate that eCIRP is released into the cerebrospinal fluid and microglial expression of crucial efferocytic receptor MerTK decreases in tMCAO mice. CIRP deficiency significantly improved neurological deficit, MerTK expression and microglial efferocytosis in tMCAO mice. Utilizing tMCAO, hippocampal injections, and primary microglia, we show that eCIRP induces pro-inflammatory micro-RNA 155 (miR-155) via TLR4, which suppresses its target pro-efferocytic transcription factor MAF bZIP (MafB), downregulating MerTK and microglial efferocytosis. Pharmacological blockade of eCIRP-TLR4 interaction using small peptide C23 attenuates miR-155 induction, restores MerTK expression, rescues microglial efferocytosis, and improves outcomes in tMCAO mice. Conclusion: We show that eCIRP causes microglial efferocytic dysfunction in ischemic stroke via TLR4/miR-155/MafB axis. These findings uncover a previously unknown pathway through which eCIRP signaling impairs neuroprotective function in microglia and suggest that targeting eCIRP may promote functional recovery after stroke.
SN  - 2198-3844
ER  -